(AGM) Federal Agricultural - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US3131483063
Stock: Farm Loans, Rural Loans, Securities, Investments
Total Rating 30
Risk 72
Buy Signal -0.88
| Risk 5d forecast | |
|---|---|
| Volatility | 31.2% |
| Relative Tail Risk | -4.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.75 |
| Alpha | -40.23 |
| Character TTM | |
|---|---|
| Beta | 0.955 |
| Beta Downside | 1.940 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.54% |
| CAGR/Max DD | 0.22 |
EPS (Earnings per Share)
Revenue
Description: AGM Federal Agricultural March 05, 2026
Federal Agricultural Mortgage Corporation (AGM) operates as a government-sponsored enterprise providing a secondary market for agricultural and rural utility loans in the United States. Its business model involves purchasing, guaranteeing, and servicing loans, as well as issuing securities backed by these loans.
The company diversifies its operations across seven segments. The Farm & Ranch and Corporate AgFinance segments focus on traditional agricultural lending, serving both individual farms and larger agribusinesses. The Power & Utilities and Broadband Infrastructure segments support rural development by financing electric cooperatives and broadband expansion, respectively. The Renewable Energy segment funds projects in rural areas, aligning with broader trends in sustainable energy. The Funding and Investments segments manage the companys capital structure and liquidity.
AGMs role as a secondary market participant helps ensure liquidity for lenders in the agricultural sector, which can face unique economic cycles. Understanding these diverse revenue streams is crucial for evaluating AGMs financial health. You can continue your research on ValueRay for more detailed financial analysis.
Headlines to watch out for
- Agricultural loan demand impacts Farm & Ranch segment revenue
- Interest rate fluctuations affect funding costs and investment income
- Regulatory changes in agricultural finance pose compliance risks
- Government agricultural policies influence loan portfolio performance
- Economic health of rural America drives borrower credit quality
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 207.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -1.71 > 1.0 |
| NWC/Revenue: -752.9% < 20% (prev 122.5%; Δ -875.5% < -1%) |
| CFO/TA 0.00 > 3% & CFO 80.1m > Net Income 207.4m |
| Current Ratio: 0.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (12.9m) vs 12m ago 17.68% < -2% |
| Gross Margin: 29.47% > 18% (prev 0.22%; Δ 2.92k% > 0.5%) |
| Asset Turnover: 3.94% > 50% (prev 5.19%; Δ -1.24% > 0%) |
| Interest Coverage Ratio: 0.04 > 6 (EBITDA TTM 255.7m / Interest Expense TTM 1.10b) |
Altman Z'' -1.70
| A: -0.28 (Total Current Assets 1.35b - Total Current Liabilities 11.27b) / Total Assets 35.51b |
| B: 0.03 (Retained Earnings 1.05b / Total Assets 35.51b) |
| C: 0.00 (EBIT TTM 40.3m / Avg Total Assets 33.42b) |
| D: 0.03 (Book Value of Equity 1.07b / Total Liabilities 33.79b) |
| Altman-Z'' Score: -1.70 = D |
Beneish M
| DSRI: 1.41 (Receivables 414.4m/361.1m, Revenue 1.32b/1.62b) |
| GMI: 0.76 (GM 29.47% / 22.38%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 0.81 (Revenue 1.32b / 1.62b) |
| TATA: 0.00 (NI 207.4m - CFO 80.1m) / TA 35.51b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of AGM shares?
As of March 24, 2026, the stock is trading at USD 142.75 with a total of 81,057 shares traded.
Over the past week, the price has changed by -4.69%, over one month by -7.28%, over three months by -18.29% and over the past year by -24.21%.
Over the past week, the price has changed by -4.69%, over one month by -7.28%, over three months by -18.29% and over the past year by -24.21%.
Is AGM a buy, sell or hold?
Federal Agricultural has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy AGM.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AGM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 215 | 50.6% |
| Analysts Target Price | 215 | 50.6% |
AGM Fundamental Data Overview March 24, 2026
P/E Trailing = 8.438
P/E Forward = 7.2359
P/S = 4.0892
P/B = 1.2573
P/EG = 0.6578
Revenue TTM = 1.32b USD
EBIT TTM = 40.3m USD
EBITDA TTM = 255.7m USD
Long Term Debt = 21.92b USD (from longTermDebt, last quarter)
Short Term Debt = 11.27b USD (from shortTermDebt, last quarter)
Debt = 30.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.89b USD (from netDebt column, last quarter)
Enterprise Value = 13.86b USD (1.52b + Debt 30.82b - CCE 18.48b)
Interest Coverage Ratio = 0.04 (Ebit TTM 40.3m / Interest Expense TTM 1.10b)
EV/FCF = 173.2x (Enterprise Value 13.86b / FCF TTM 80.1m)
FCF Yield = 0.58% (FCF TTM 80.1m / Enterprise Value 13.86b)
FCF Margin = 6.07% (FCF TTM 80.1m / Revenue TTM 1.32b)
Net Margin = 15.73% (Net Income TTM 207.4m / Revenue TTM 1.32b)
Gross Margin = 29.47% ((Revenue TTM 1.32b - Cost of Revenue TTM 929.8m) / Revenue TTM)
Gross Margin QoQ = none% (prev 22.93%)
Tobins Q-Ratio = 0.39 (Enterprise Value 13.86b / Total Assets 35.51b)
Interest Expense / Debt = 0.61% (Interest Expense 187.5m / Debt 30.82b)
Taxrate = 20.79% (12.6m / 60.5m)
NOPAT = 31.9m (EBIT 40.3m * (1 - 20.79%))
Current Ratio = 0.12 (Total Current Assets 1.35b / Total Current Liabilities 11.27b)
Debt / Equity = 17.93 (Debt 30.82b / totalStockholderEquity, last quarter 1.72b)
Debt / EBITDA = 116.9 (Net Debt 29.89b / EBITDA 255.7m)
Debt / FCF = 373.4 (Net Debt 29.89b / FCF TTM 80.1m)
Total Stockholder Equity = 1.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.62% (Net Income 207.4m / Total Assets 35.51b)
RoE = 12.81% (Net Income TTM 207.4m / Total Stockholder Equity 1.62b)
RoCE = 0.17% (EBIT 40.3m / Capital Employed (Equity 1.62b + L.T.Debt 21.92b))
RoIC = 0.10% (NOPAT 31.9m / Invested Capital 32.50b)
WACC = 0.90% (E(1.52b)/V(32.35b) * Re(9.34%) + D(30.82b)/V(32.35b) * Rd(0.61%) * (1-Tc(0.21)))
Discount Rate = 9.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.58%
[DCF] Terminal Value 84.41% ; FCFF base≈291.0m ; Y1≈244.7m ; Y5≈183.6m
[DCF] Fair Price = N/A (negative equity: EV 5.58b - Net Debt 29.89b = -24.31b; debt exceeds intrinsic value)
EPS Correlation: 77.33 | EPS CAGR: 12.29% | SUE: -4.0 | # QB: 0
Revenue Correlation: 29.86 | Revenue CAGR: -6.20% | SUE: 2.28 | # QB: 1
EPS next Quarter (2026-06-30): EPS=4.65 | Chg7d=-0.040 | Chg30d=-0.040 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-12-31): EPS=18.86 | Chg7d=-0.383 | Chg30d=-0.383 | Revisions Net=-1 | Growth EPS=+13.2% | Growth Revenue=+12.2%
EPS next Year (2027-12-31): EPS=20.82 | Chg7d=+0.497 | Chg30d=+0.497 | Revisions Net=+0 | Growth EPS=+10.4% | Growth Revenue=+10.9%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.5% (Discount Rate 9.3% - Earnings Yield 11.9%)
[Growth] Growth Spread = +15.4% (Analyst 12.8% - Implied -2.5%)
P/E Forward = 7.2359
P/S = 4.0892
P/B = 1.2573
P/EG = 0.6578
Revenue TTM = 1.32b USD
EBIT TTM = 40.3m USD
EBITDA TTM = 255.7m USD
Long Term Debt = 21.92b USD (from longTermDebt, last quarter)
Short Term Debt = 11.27b USD (from shortTermDebt, last quarter)
Debt = 30.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.89b USD (from netDebt column, last quarter)
Enterprise Value = 13.86b USD (1.52b + Debt 30.82b - CCE 18.48b)
Interest Coverage Ratio = 0.04 (Ebit TTM 40.3m / Interest Expense TTM 1.10b)
EV/FCF = 173.2x (Enterprise Value 13.86b / FCF TTM 80.1m)
FCF Yield = 0.58% (FCF TTM 80.1m / Enterprise Value 13.86b)
FCF Margin = 6.07% (FCF TTM 80.1m / Revenue TTM 1.32b)
Net Margin = 15.73% (Net Income TTM 207.4m / Revenue TTM 1.32b)
Gross Margin = 29.47% ((Revenue TTM 1.32b - Cost of Revenue TTM 929.8m) / Revenue TTM)
Gross Margin QoQ = none% (prev 22.93%)
Tobins Q-Ratio = 0.39 (Enterprise Value 13.86b / Total Assets 35.51b)
Interest Expense / Debt = 0.61% (Interest Expense 187.5m / Debt 30.82b)
Taxrate = 20.79% (12.6m / 60.5m)
NOPAT = 31.9m (EBIT 40.3m * (1 - 20.79%))
Current Ratio = 0.12 (Total Current Assets 1.35b / Total Current Liabilities 11.27b)
Debt / Equity = 17.93 (Debt 30.82b / totalStockholderEquity, last quarter 1.72b)
Debt / EBITDA = 116.9 (Net Debt 29.89b / EBITDA 255.7m)
Debt / FCF = 373.4 (Net Debt 29.89b / FCF TTM 80.1m)
Total Stockholder Equity = 1.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.62% (Net Income 207.4m / Total Assets 35.51b)
RoE = 12.81% (Net Income TTM 207.4m / Total Stockholder Equity 1.62b)
RoCE = 0.17% (EBIT 40.3m / Capital Employed (Equity 1.62b + L.T.Debt 21.92b))
RoIC = 0.10% (NOPAT 31.9m / Invested Capital 32.50b)
WACC = 0.90% (E(1.52b)/V(32.35b) * Re(9.34%) + D(30.82b)/V(32.35b) * Rd(0.61%) * (1-Tc(0.21)))
Discount Rate = 9.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.58%
[DCF] Terminal Value 84.41% ; FCFF base≈291.0m ; Y1≈244.7m ; Y5≈183.6m
[DCF] Fair Price = N/A (negative equity: EV 5.58b - Net Debt 29.89b = -24.31b; debt exceeds intrinsic value)
EPS Correlation: 77.33 | EPS CAGR: 12.29% | SUE: -4.0 | # QB: 0
Revenue Correlation: 29.86 | Revenue CAGR: -6.20% | SUE: 2.28 | # QB: 1
EPS next Quarter (2026-06-30): EPS=4.65 | Chg7d=-0.040 | Chg30d=-0.040 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-12-31): EPS=18.86 | Chg7d=-0.383 | Chg30d=-0.383 | Revisions Net=-1 | Growth EPS=+13.2% | Growth Revenue=+12.2%
EPS next Year (2027-12-31): EPS=20.82 | Chg7d=+0.497 | Chg30d=+0.497 | Revisions Net=+0 | Growth EPS=+10.4% | Growth Revenue=+10.9%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.5% (Discount Rate 9.3% - Earnings Yield 11.9%)
[Growth] Growth Spread = +15.4% (Analyst 12.8% - Implied -2.5%)